MAGSIL CORP. v. Seagate Technology
764 F. Supp. 2d 674
D. Del.2011Background
- Plaintiffs MagSil Corp. and MIT own/license the '922 patent on ferromagnetic tunnel junctions.
- Defendants Hitachi entities sell HDDs/components allegedly infringing claims 1-5, 23-26, 28.
- Independent claims require a junction with at least 10% resistance change at room temperature upon energy input.
- The specification discloses resistance changes up to 11.8% and provides enabling details for certain embodiments.
- The asserted claims are broad with no upper limit on resistance change, potentially covering infinite change.
- Court grants summary judgment for lack of enablement, invalidating claims 1-5, 23-26, 28; other issues denied as moot.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Enablement of full claim scope | Magsil/MIT contends the patent enables broad 10%+ changes via enabling disclosure. | Seagate argues specification fails to enable changes beyond disclosed embodiments without undue experimentation. | Not enabled; claims invalid for lack of enablement. |
Key Cases Cited
- In re Fisher, 427 F.2d 833 (C.C.P.A. 1970) (enablement must correlate claim scope to enablement)
- Genentech v. Novo Nordisk, 108 F.3d 1361 (Fed. Cir. 1991) ( Written description and enablement standards apply to full claim scope)
- AK Steel Corp. v. Sollac, 344 F.3d 1234 (Fed. Cir. 2003) (Wands factors and enablement analysis require undue experimentation inquiry)
- Sitrick v. Dreamworks, LLC, 516 F.3d 993 (Fed. Cir. 2008) (enablement scope must match claims; speculative breadth problematic)
- Plant Genetic Sys. v. DeKalb Genetics Corp., 315 F.3d 1335 (Fed. Cir. 2003) (claims must bear reasonable correlation to enablement; monocots vs dicots example)
- U.S. Steel Corp. v. Phillips Petroleum Co., 865 F.2d 1247 (Fed. Cir. 1989) (enablement not defeated by post-inventive art asserting possible future improvements)
- Hormone Research Foundation v. Genentech, Inc., 904 F.2d 1558 (Fed. Cir. 1990) (discussion of enabling disclosures when higher potency still uncertain)
- In re Hogan, 559 F.2d 595 (C.C.P.A. 1977) (enablement assessed against scope of what is disclosed at filing)